Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,351.80
-3.70 (-0.27%)
Jun 19, 2026, 3:29 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.09 trillion as of June 18, 2026. Its market cap has decreased by -7.76% in one year.
Market Cap
1.09T
Enterprise Value
998.72B
Revenue
278.28B
Ranking
n/a
PE Ratio
28.16
Stock Price
1,351.80
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.09T, an increase of 72,040.01%. That is a compound annual growth rate of 24.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 1.09T | -10.55% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.79T |
| Zydus Lifesciences | 1.08T |
| Mankind Pharma | 996.65B |
| Aurobindo Pharma | 861.80B |
| Laurus Labs | 762.76B |
| Alkem Laboratories | 642.48B |
| Glenmark Pharmaceuticals | 624.68B |
| Ipca Laboratories | 402.32B |